Da-Li Development Co.,Ltd. (TPE:6177)

Market Cap	20.67B
Revenue (ttm)	12.40B
Net Income (ttm)	2.07B
Shares Out	448.85M
EPS (ttm)	4.81
PE Ratio	9.58
Forward PE	9.44
Dividend	2.86 (6.25%)
Ex-Dividend Date	Aug 5, 2025

Volume	1,582,781
Average Volume	1,259,411
Open	46.05
Previous Close	46.05
Day's Range	45.25 - 46.05
52-Week Range	38.15 - 73.90
Beta	0.15
RSI	37.43
Earnings Date	Aug 8, 2025

About Singular Genomics Systems

Da-Li Development Co.,Ltd., together with its subsidiaries, engages in the construction business in Taiwan and the United States. It operates through the Development and Construction segments. The company is also involved in the sale and rental business of residential buildings and department stores, as well as real estate investment and brokerage. Da-Li Development Co.,Ltd. was incorporated in 1977 and is headquartered in Taipei, Taiwan.

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1977
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6177

Financial Performance

In 2024, Da-Li Development's revenue was 12.32 billion, a decrease of -20.13% compared to the previous year's 15.43 billion. Earnings were 2.15 billion, an increase of 3.94%.